MedTrace Logo

Clomid in Men With Low Testosterone With and Without Prior Treatment

NCT01904734 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2021-03-10

No results posted yet for this study

Summary

This study aims to explore whether men with low testosterone levels, due to altered brain regulation of male hormone function, who have been previously treated with testosterone, respond as well as men who have not been so treated to clomiphene citrate, an agent commonly used for female infertility that has been shown to improve male hormone secretion in some cases.

Conditions

  • Hypogonadism, Male

Interventions

DRUG

Clomiphene

Start with 25 mg and escalate to 50 mg in men not achieving goal for serum testosterone after 3 weeks

Sponsors & Collaborators

  • Phoenix VA Health Care System

    lead FED

Principal Investigators

  • Sherman M Harman, MD, PhD · Phoenix VA Health Care System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2018-10-31
Completion
2018-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01904734 on ClinicalTrials.gov